Cargando…
333. Comparing COVID-19-related Morbidity and Mortality between Patients with and without Substance Use Disorder: A Retrospective Cohort Study
BACKGROUND: Early data suggest that people with substance use disorder (SUD) who develop coronavirus disease 2019 (COVID-19) have increased intubation and mortality rates when compared to those without SUD. Information on other COVID-19-related complications in this population is limited. We evaluat...
Autores principales: | McLaughlin, Angela, Burns, Rebecca, Ryan, Morgan, Assoumou, Sabrina A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644990/ http://dx.doi.org/10.1093/ofid/ofab466.534 |
Ejemplares similares
-
Comparing COVID-19-related Morbidity and Mortality Between Patients
With and Without Substance Use Disorders: A Retrospective Cohort
Study
por: McLaughlin, Angela, et al.
Publicado: (2023) -
Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
por: Lähteenvuo, M., et al.
Publicado: (2021) -
333. Tedizolid Activity against Gram-Positive Bacterial Isolates Causing Bone and Joint Infections in the United States (2015–2019)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2020) -
Factors associated with inpatient complications among patients with obesity and COVID‐19 at an urban safety‐net hospital: A retrospective cohort study
por: Ryan, Tyler J., et al.
Publicado: (2022) -
PM333. Transcriptomic immaturity of hippocampus and prefrontal cortex in patients with alcoholism
por: Murano, Tomoyuki, et al.
Publicado: (2016)